Statistical analysis
toxicity, tumor, non-segmental
TUMOR
Receiver operating characteristic (ROC) analysis was used to determine what tumor dose and dosimetric variable predicted complete response (CR) or objective response (OR) as well as which non-tumoral liver dose (NTLD) predicted any clinical toxicity or severe, grade 3 or greater, treatment related toxicity. Comparisons between dosimetric measurements (segmental treatment vs non-segmental treatment) were performed using paired Student’s This cohort was previously described as a proof-of-concept study evaluating the accuracy of “scout” low-dose Y90 as a mapping agent compared to Tc99 MAA (PMID: 36,075,560) [